Literature DB >> 27063826

Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention.

Zoltan Csanadi1, Edina Nagy-Baló2, Stephan Danik3, Conor Barrett3, J David Burkhardt4, Javier Sanchez4, Pasquale Santangeli5, Francesco Santoro6, Luigi Di Biase7, Andrea Natale8.   

Abstract

Transcatheter treatment of atrial fibrillation (AF) is a complex intervention performed in patients who are at inherently increased risk of a thromboembolic complication, including stroke. It is therefore not surprising that cerebrovascular accidents have been among the most feared complications since the inception of AF ablation. While improvements have been made to limit the incidence of thromboembolic events during catheter ablation of AF, the optimal strategy to minimize such complications has yet to be determined. It is hoped that larger trials using periprocedural anticoagulation strategies can be undertaken to definitively address these important concerns.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Diffusion-weighted cerebral magnetic resonance imaging; Silent cerebral ischemia; Stroke; Transcranial Doppler

Year:  2014        PMID: 27063826     DOI: 10.1016/j.ccep.2013.10.003

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  2 in total

Review 1.  Pulmonary Vein Isolation with the Multipolar nMARQ™ Ablation Catheter: Efficacy And Safety In Acute And Long-Term Follow Up.

Authors:  Johannes Siebermair; Michelle Silver; Reza Wakili
Journal:  J Atr Fibrillation       Date:  2017-04-30

2.  Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.

Authors:  Orsolya Hajas; Zsuzsa Bagoly; Noémi K Tóth; Réka Urbancsek; Alexandra Kiss; Kitti B Kovács; Ferenc Sarkady; Attila Nagy; Anna V Oláh; László Nagy; Marcell Clemens; László Csiba; Zoltán Csanádi
Journal:  Cardiol Res Pract       Date:  2020-02-12       Impact factor: 1.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.